Brief: ADC Therapeutics Q4 Net Income USD -30.727 Million
27/03/2025 12:40
March 27 (Reuters) - ADC Therapeutics SA ADCT.N: ADC THERAPEUTICS Q4 NET INCOME USD -30.727 MILLION ADC THERAPEUTICS Q4 OPERATING EXPENSES USD -49.346 MILLION ADC THERAPEUTICS Q4 BASIC EPS USD -0.29 ADC THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -32.436 MILLION $250.9M IN CASH AS OF DECEMBER 31, 2024, PROVIDES RUNWAY EXPECTED TO FUND OPERATIONS INTO SECOND HALF OF 2026 Source text: ID:nPn37Y0xza Further company coverage: ADCT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ADC Therapeutics SA
See all newsADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Switzerland's ADC Therapeutics beats Q1 revenue estimates
Switzerland's ADC Therapeutics posts smaller‑than‑expected Q4 net loss on lower R&D spend
Brief: ADC Therapeutics Q4 Income From Operations USD -17.919 Million Vs. IBES Estimate USD -30.1 Million